Case Study: Named Patient Program
Global Named Patient Supply Program Scales to Meet Demand
100% SLA Response. 100% Seamless Distribution.
The Challenge
A leading pharmaceutical manufacturer experienced a rapid surge in international demand for one of its therapies following increased global market awareness. However, the organization lacked the internal resources required to manage the growing volume of international inquiries and the operational complexity of export-import logistics.
Without a dedicated infrastructure to support global Named Patient Supply and cross-border fulfillment, the manufacturer risked delayed responses to healthcare providers and potential disruptions to patient access.
Our Approach
Tanner partnered with the manufacturer as its dedicated international fulfillment and Ex-US customer service partner to support rising demand through a structured Named Patient Program (NPP). Each international request was reviewed and validated by Tanner’s global access specialists to ensure compliance with country-specific regulatory requirements before fulfillment.
Leveraging Tanner’s GDP-compliant global supply chain and warehouse network, the team streamlined distribution, coordinated regulatory documentation, and provided end-to-end shipment visibility. With more than two decades of experience supporting Named Patient Supply and Medication Global Access, Tanner ensured each shipment met local import regulations, pharmacovigilance requirements, and EU-GDP standards while enabling rapid global distribution.
